112 related articles for article (PubMed ID: 26933481)
21. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
[TBL] [Abstract][Full Text] [Related]
22. Generation of a polyclonal antibody specifically against the p33(ING1b) tumor suppressor.
Campos EI; Xiao H; Li G
J Immunoassay Immunochem; 2004; 25(1):71-80. PubMed ID: 15038618
[TBL] [Abstract][Full Text] [Related]
23. The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer.
Ahmed IA; Kelly SB; Anderson JJ; Angus B; Challen C; Lunec J
Colorectal Dis; 2008 May; 10(4):344-51. PubMed ID: 17949449
[TBL] [Abstract][Full Text] [Related]
24. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner.
Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K
Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053
[TBL] [Abstract][Full Text] [Related]
25. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.
Chen LS; Wei JB; Zhou YC; Zhang S; Liang JL; Cao YF; Tang ZJ; Zhang XL; Gao F
World J Gastroenterol; 2005 Oct; 11(39):6120-4. PubMed ID: 16273637
[TBL] [Abstract][Full Text] [Related]
26. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
Ai Zheng; 2003 Jul; 22(7):680-5. PubMed ID: 12866955
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
28. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
[TBL] [Abstract][Full Text] [Related]
29. p37Ing1b regulates B-cell proliferation and cooperates with p53 to suppress diffuse large B-cell lymphomagenesis.
Coles AH; Marfella CG; Imbalzano AN; Steinman HA; Garlick DS; Gerstein RM; Jones SN
Cancer Res; 2008 Nov; 68(21):8705-14. PubMed ID: 18974112
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
31. ING1b decreases cell proliferation through p53-dependent and -independent mechanisms.
Tsang FC; Po LS; Leung KM; Lau A; Siu WY; Poon RY
FEBS Lett; 2003 Oct; 553(3):277-85. PubMed ID: 14572637
[TBL] [Abstract][Full Text] [Related]
32. [p33(ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues].
Ding HZ; Yang D; Wu FR; Li H; Feng K; Zheng SJ; Ni CR; Yu GZ
Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):320-3. PubMed ID: 12812652
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of human leukocyte antigen F-associated transcript 10 expression in colorectal cancer.
Zhang CY; Sun J; Wang X; Wang CF; Zeng XD
World J Gastrointest Oncol; 2019 Jan; 11(1):9-16. PubMed ID: 30984346
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor Ing1b facilitates DNA repair and prevents oxidative stress induced cell death.
Rotte A; Li G; Bhandaru M
Apoptosis; 2014 Mar; 19(3):518-26. PubMed ID: 24242916
[TBL] [Abstract][Full Text] [Related]
35. Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.
Boyko A; Riabowol K
Cell Death Discov; 2015; 1():15048. PubMed ID: 27551477
[TBL] [Abstract][Full Text] [Related]
36. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2.
Leung KM; Po LS; Tsang FC; Siu WY; Lau A; Ho HT; Poon RY
Cancer Res; 2002 Sep; 62(17):4890-3. PubMed ID: 12208736
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Immuno-Histochemical Expression of MBD1 in Colorectal Adenocarcinoma and Its Correlations with Prognostic Factors.
Ghaedamini S; Nikbakht M; Soleimani M
Middle East J Dig Dis; 2020 Jan; 12(1):39-44. PubMed ID: 32082520
[TBL] [Abstract][Full Text] [Related]
38. LincRNA-p21 acts as a mediator of ING1b-induced apoptosis.
Tran UM; Rajarajacholan U; Soh J; Kim TS; Thalappilly S; Sensen CW; Riabowol K
Cell Death Dis; 2015 Mar; 6(3):e1668. PubMed ID: 25741593
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of microRNA-126 is inversely correlated with insulin receptor substrate-1 protein expression in colorectal cancer and is associated with advanced stages of disease.
Ye S; Yu C; Zhang G; Shi F; Chen Y; Yang J; Wu W; Zhou Y
Oncol Lett; 2020 Sep; 20(3):2411-2419. PubMed ID: 32782558
[TBL] [Abstract][Full Text] [Related]
40. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
